본문 바로가기

Prospective Cohort Study on the Effectiveness of Influenza and Pneumococcal Vaccines in Preventing Pneumonia Development and Hospitalization

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
Scopus Q1
저널
CLINICAL AND VACCINE IMMUNOLOGY22(2) · pp.229 · 2015
피인용
Web of Science 23
JCR IF
JCR 2014 2.47
ISSN
1556-6811

저자

  1. Song, Joon Young제1저자Department of Internal Medicine, Korea University College of Medicine, Seoul, South Korea
  2. Lee, Jin SooInha University School of Medicine, Incheon, South Korea
  3. Wie, Seong-HeonCatholic University Medical College, St. Vincent's Hospital, Suwon, South Korea
  4. Kim, Hyo YoulYonsei University, Wonju College of Medicine, Wonju, South Korea
  5. Lee, JacobHallym University College of Medicine, Chuncheon, South Korea
  6. Seo, Yu BinHallym University College of Medicine, Chuncheon, South Korea
  7. Jeong, Hye WonChungbuk National University College of Medicine, Cheongju, South Korea
  8. Kim, Shin WooKyungpook National University School of Medicine, Daegu, South Korea
  9. 이선희Pusan National University School of Medicine, Pusan, South Korea
  10. Park, Kyung-HwaChonnam National University Medical School, Gwangju, South Korea
  11. Noh, Ji YunDepartment of Internal Medicine, Korea University College of Medicine, Seoul, South Korea
  12. Choi, Won SukDepartment of Internal Medicine, Korea University College of Medicine, Seoul, South Korea
  13. Cheong, Hee JinDepartment of Internal Medicine, Korea University College of Medicine, Seoul, South Korea
  14. Kim, Woo Joo교신저자Department of Internal Medicine, Korea University College of Medicine, Seoul, South Korea

초록

Pneumonia and acute exacerbation of chronic illness are leading causes of influenza-related hospitalization. Therefore, influenza and pneumococcal vaccinations are strongly recommended for adults with comorbidities. Using a hospital-based influenza surveillance system, we performed a multicenter, prospective cohort study of patients visiting emergency rooms with influenza-like illness (ILI) during the influenza epidemic period in 2013 to 2014. Patients aged >= 19 years were enrolled, and clinical data were collected. Multivariate analyses were performed to estimate the effectiveness of influenza and pneumococcal vaccination in preventing pneumonia development and hospitalization. During study periods, 2,262 patients with ILI were registered. Among 2,217 patients with available vaccination records, 31.9% (707 patients) and 9.7% (216 patients) had received influenza and pneumococcal vaccines, respectively. Among patients who had been administered a pneumococcal vaccine, 94.4% had received the 23-valent polysaccharide vaccine (PPV23). The adjusted rates of effectiveness of the influenza vaccine for preventing pneumonia development and hospitalization were 64.0% (95% confidence interval [CI] = 29% to 81%) and 35.0% (95% CI = 12% to 52%), respectively. Pneumococcal vaccination did not reduce pneumonia development or hospitalization. In conclusion, influenza rather than PPV23 vaccination may reduce pneumonia development and hospitalization in patients with preceding ILI.

키워드

LABORATORY-CONFIRMED INFLUENZARESPIRATORY SYNCYTIAL VIRUSBACTERIAL PNEUMONIAELDERLY PERSONSOLDER-ADULTSVACCINATIONSEASONSKOREASURVEILLANCEDISEASE

식별자

WoS UID
000348772200012